Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary.
about
Modulation of MUC7 mucin expression by exogenous factors in airway cells in vitro and in vivoThe molecular background of mucinous carcinoma beyond MUC2Mucins in ovarian cancer diagnosis and therapyHistochemical and immunohistochemical study of mucinous rectal carcinoma.Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.Relationships between mucinous gastric carcinoma, MUC2 expression and survival.Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast.Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucinsPulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal modelPromotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseasesPrimary retroperitoneal mucinous cystadenocarcinoma in a male patient.Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model.Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma.Clinicopathological Significance of Mucin 2 Immuno-histochemical Expression in Colorectal Cancer: A Meta-AnalysisA Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature ReviewImmunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis.Expression of metabolism-related proteins in triple-negative breast cancerMUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.Mucin-rich salivary duct carcinoma with signet-ring cell feature ex pleomorphic adenoma of the submandibular gland: a case report of an unusual histology with immunohistochemical analysis and review of the literature.Mucinous carcinoma of the rectum: a distinct clinicopathological entity.Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.Mucinous Variant of Follicular Carcinoma of the Thyroid Gland: Case Report and Review of the Literature.Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft.Multicystic urothelial carcinoma of the bladder with gland-like lumina and with signet-ring cells. A case report.Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases.Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells.Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas.Differential expression of mucin 1 and mucin 2 in colorectal cancer
P2860
Q24654993-91896D58-1CBA-45DC-9D5B-8F9701458E1AQ28083904-6E084E2B-E513-4980-8883-20DDC329205CQ33583166-0EAFEDFF-0AB5-4BAA-A405-9455048F8C92Q33786579-1764FB2A-3164-4A0D-9365-8014541BB33AQ33825288-0A5675FF-9626-4428-B5B5-464E57A8ABFFQ33867941-953D17A5-9777-4929-BE7C-4B08980689BAQ34032146-E365FE70-6CF4-4F8A-8D1F-EFAEAA986207Q34253326-9F6A1F9B-6C2C-4130-B38D-1644FA600640Q34375540-21E32AC9-FB6B-4E7E-AF08-1CD36D35786AQ34377419-B407D0D9-0D16-493F-9CA8-3DA3FA70474FQ34556778-F5A62F2B-678D-4BBE-B7E1-06F42D191306Q34786193-78AF0E9B-7ED1-4404-A54D-DD7F1A00D55CQ35472040-EC2713AE-1DE7-48E3-ADDC-75717F0991D3Q35770051-A5FCE993-FB17-4FC2-BB0D-AAED0C8745C4Q36076481-5D86A9E5-41C8-4A3A-8069-7D80E160AE67Q36413690-14E18741-E84C-4D83-A8AA-8EAB970153CEQ36518796-67286E6E-C9B1-4E46-910A-28C8D76AB9D6Q36563169-62541B8B-AC9C-4D22-BCA4-86C8DA3E1992Q36832221-19DBF2F1-7388-4B25-8054-D395C439182CQ36933835-DF2B4B59-98A7-4982-8A0F-0AE8E646F15DQ37452279-049F1F0E-4FB7-4D4A-B022-A126ACF23A86Q37604087-D1CDEA11-5C77-4CFD-8B8A-FACDCC585295Q37995118-C8B0DDF1-CAC7-44F1-9A6C-455498949B1CQ38170278-476D0FCA-7901-4411-BE8A-B2B2C2BF1D63Q38399502-AE07E312-AFFD-43EB-90EB-34A80AF437BBQ38638117-F727319B-6E98-42C5-9DC8-4E6719F7F82CQ38796817-83B2E2BF-6DE4-4F27-9FCF-A7DB0CA2403FQ42745537-76ECC24E-DEB9-4462-A98F-809EF2E7FFD7Q50871791-BD910A0C-14E7-4054-94E8-6CF49808097CQ51732351-54439683-8739-47B8-835E-426C3F516110Q52982762-7BF3EE61-1580-4CEC-85B2-E5E287677D29Q52996565-29761702-1A63-455B-9A7C-782F4CF2F66DQ54759302-2C7DBFAC-6385-4C84-8CEA-0699B91C6550Q55026142-DAB3C548-CBE0-416F-8967-A3E80AC95EBFQ57067863-1CA54A7E-994C-4B5F-8418-B832DC4581FB
P2860
Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@en
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@nl
type
label
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@en
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@nl
prefLabel
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@en
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@nl
P2093
P2860
P1476
Overexpression or ectopic expr ...... , pancreas, breast, and ovary.
@en
P2093
Borchard F
Hofmeier M
Niedobitek F
Riecken EO
Schmitt-Gräff A
P2860
P304
P356
10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q
P577
1997-08-01T00:00:00Z